Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Safety Concerns Are US FDA's Answer To Question On Regulatory Pathway For Hemp’s Lawful Use
Jun 15 2022
•
By
Malcolm Spicer
FDA officials explained and showed Science Board members about hemp's de-scheduling not changing its regulatory status at the agency. • Source: FDA
Explore how consumer health is evolving. On the go.
David Ridley hosts in-depth conversations with industry leaders.
More from Cannabis/CBD
More from Ingredients & Safety